Brinker Capital Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-15,719
Closed -$292K – 1752
2023
Q3
$292K Buy
15,719
+223
+1% +$5.21K ﹤0.01% 1396
2023
Q2
$392K Buy
15,496
+1,151
+8% +$29K ﹤0.01% 1304
2023
Q1
$372K Buy
+14,345
New +$384K ﹤0.01% 1265
2021
Q4
– Sell
-3,142
Closed -$522K – 1435
2021
Q3
$522K Hold
3,142
– – 0.01% 960
2021
Q2
$522K Sell
3,142
-172
-5% -$27.9K 0.01% 1016
2021
Q1
$602K Sell
3,314
-1,882
-36% -$437K 0.01% 859
2020
Q4
$1.04M Buy
5,196
+1,231
+31% +$250K 0.02% 681
2020
Q3
$869K Buy
+3,965
New +$840K 0.01% 726

Other funds holding TDOC

Brinker Capital Investments's TDOC Position: Q4 2023 in Review

Brinker Capital Investments sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 15,719 shares — an estimated $292K sold.

Brinker Capital Investments first reported a position in TDOC in Q3 2020 and held it in 8 quarters. The position peaked at $1.04M in Q4 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Brinker Capital Investments reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 15,719 Teladoc Health shares in Q4 2023, an estimated $292K.
  • Brinker Capital Investments first reported a position in Teladoc Health in Q3 2020 and held it in 8 quarters.
  • Brinker Capital Investments's Teladoc Health position peaked at $1.04M in Q4 2020.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Brinker Capital Investments's 13F filing for Q4 2023, filed 31 Jul 2025.